Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Mohamed Abu Haleeqa, MBBS, Hanan Al Raeesi, MBBS, Fatima Alkaabi, MBBS

Blood (2019) 134 (Supplement_1): 4799.

https://doi.org/10.1182/blood-2019-126479

Published: 2019

Journal Articles

Faster Diagnosis of TTP Using New Technoscreen Adamts-13 Activity Assay

Annica Braf, Henrik von Horn, Niklas Bark, Eva-Marie Norberg, Asa Truedsson, Nikolaus B Binder, MD PhD, Jovan P Antovic, MD PhD

Blood (2019) 134 (Supplement_1): 2354.

https://doi.org/10.1182/blood-2019-128131

Published: 2019

Journal Articles

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

Cesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, Piera La Cava, Alessandra Cupri, MD, PhD, Annalisa Chiarenza, MD, PhD, Fabio Stagno, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2012) 120 (21): 2779.

https://doi.org/10.1182/blood.V120.21.2779.2779

Published: 2012

Journal Articles

Dose Adjustment and Use of Alternative Eltrombopag Dosing Regimens for the Treatment of Patients with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Athanasios Galanopoulos, MD, Panagiotis Bacarakos, Dimitris Tsokanas, Ilias Minakakis, Zoi Topouzoglou, Georgia Leveta, Theodore Marinakis, Christina Papadaki, Vasiliki Grigoraki, Elpiniki Griva-Kritikou, Anagnostopoulos I. Nikolaos

Blood (2012) 120 (21): 4657.

https://doi.org/10.1182/blood.V120.21.4657.4657

Published: 2012

Journal Articles

Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)

Esther Natalie Oliva, MD, Valeria Santini, MD, Gina Zini, Giuseppe A Palumbo, Antonella Poloni, MD, Agostino Cortelezzi, MD, Maria Teresa Voso, Alfredo Molteni, Grazia Sanpaolo, MD, Antonio Marino, Filippo Rodà, MD, Caterina Alati, Francesca Ronco, Francesco Di Raimondo, Pietro Leoni, MD, Giuliana Alimena, Silvia Finotto, Roberto Latagliata, MD, Francesco Nobile, MD

Blood (2012) 120 (21): 923.

https://doi.org/10.1182/blood.V120.21.923.923

Published: 2012

Journal Articles

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Daniele Tibullo, Cesarina Giallongo, Ignazio Barbagallo, Piera La Cava, Nunziatina Parrinello, Giovanni Li Volti, Sr., Giuseppe A Palumbo, Concetta Conticello, MD, Francesco Di Raimondo

Blood (2012) 120 (21): 5005.

https://doi.org/10.1182/blood.V120.21.5005.5005

Published: 2012

Journal Articles

Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome

Blood (2011) 118 (22): 5928–5937.

https://doi.org/10.1182/blood-2011-07-365601

Published: 2011

Includes: Supplemental data

Journal Articles

Comparative Net Cost Impact of the Utilization of Romiplostim and Intravenous Immunoglobulin for the Treatment of Patients with Immune Thrombocytopenia in Quebec,

Martine Pettigrew, Robert Deuson, PhD, Kirsten Garces

Blood (2011) 118 (21): 4211.

https://doi.org/10.1182/blood.V118.21.4211.4211

Published: 2011

Journal Articles

Romiplostim Treatment Mimicking Cyclic Thrombocytopenia In 3 Patients with Chronic Idiopatic Thrombocytopenic Purpura

Francesco Iuliano, Tecla Mingrone, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Maria Luci, Massimo Di Maio

Blood (2010) 116 (21): 4665.

https://doi.org/10.1182/blood.V116.21.4665.4665

Published: 2010

Journal Articles

Characteristics of Sarcoidosis-Associated Immune Thrombocytopenia: a Consecutive Study of 20 Cases.

Matthieu Mahévas, Laurent Chiche, Medhi Khellaf, Yurdagu Uzunhan, Anne-Sophie Morin, Véronique Perronne, Louis Affo, Olivier Lidove, Jean-Pierre Ducroix, Thomas Papo, Yves Pacheco, Nicolas Schleinitz, Marc Michel, Dominique Valeyre, Bertrand Godeau

Blood (2009) 114 (22): 2407.

https://doi.org/10.1182/blood.V114.22.2407.2407

Published: 2009

Journal Articles

An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients (Pts) with Myelodysplastic Syndromes (MDS).

Pierre Fenaux, Hagop Kantarjian, MD, Roger Lyons, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Petra Muus, MD, PhD, Kuolong Hu, PhD, Dietmar Berger, MD, PhD, Janet L. Franklin, MD, MPH

Blood (2009) 114 (22): 2765.

https://doi.org/10.1182/blood.V114.22.2765.2765

Published: 2009

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).

George R. Buchanan, MD, Lisa Bomgaars, MD, James B. Bussel, MD, Diane J. Nugent, MD, David J. Gnarra, MD, Victor S Blanchette, FRCP, Kun Nie, Melissa Eisen, MD, Dietmar Berger, MD, PhD

Blood (2009) 114 (22): 680.

https://doi.org/10.1182/blood.V114.22.680.680

Published: 2009

Journal Articles

Defining the Molecular Mechanisms Responsible for the ABO High Expresser Phenotype.

Diarmaid O Donghaile, MD, Vince P Jenkins, PhD, Rachel McGrath, BSc, Lisa Preston, MSc, Roger JS Preston, PhD, William G Murphy, James S O'Donnell, MD, PhD

Blood (2009) 114 (22): 2119.

https://doi.org/10.1182/blood.V114.22.2119.2119

Published: 2009

Journal Articles

PTPN22 Mutation Is Present in An Increased Proportion of ITP Patients.

Karl D’Silva, MD, Mathew Zamora, BS, John Gerlach, PhD, Kenneth A. Schwartz, MD

Blood (2008) 112 (11): 3418.

https://doi.org/10.1182/blood.V112.11.3418.3418

Published: 2008

Journal Articles

Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Treatment Pattern and Splenectomy Rate from a Multinational Prospective Observational Study

Francesco Rodeghiero, MD, Axel C. Matzdorff, MD, Tiziano Barbui, MD, Jean- Francois Viallard, MD, PhD, Naveed M. Chowhan, MD, Robert Robles, MD, Boriana Kamenova, MD, Ze Cong, MS, Robert Deuson, PhD, John J. Isitt, MS

Blood (2008) 112 (11): 4538.

https://doi.org/10.1182/blood.V112.11.4538.4538

Published: 2008

Journal Articles

Immune Thrombocytopenic Purpura Due to Passenger Donor Lymphocytes in Liver Transplantation

Imran Mirza, MD, FRCPC, Areej Almugairi, MD, Susan Nahirniak, MD, FRCPC

Blood (2008) 112 (11): 4558.

https://doi.org/10.1182/blood.V112.11.4558.4558

Published: 2008

Journal Articles

Treatment of Idiopathic (autoimmune) Thrombocytopenic Purpura (ITP): A Single Mexican Institution Experience

Gregorio Campos-Cabrera, Virgina Campos-Cabrera, Augusto Gomez-Leal, Fernando Gomez-Garcia, Jose-Luis Campos-Villagomez

Blood (2008) 112 (11): 4559.

https://doi.org/10.1182/blood.V112.11.4559.4559

Published: 2008

Journal Articles

Deferasirox Efficacy and Safety for the Treatment of Transfusion- Dependent Iron Overload in Patients with a Range of Rare Anemias.

John B Porter, Kai-Hsin Lin, Dany Habr, Gabor Domokos, Abdel Hmissi, Swee Lay Thein

Blood (2008) 112 (11): 1419.

https://doi.org/10.1182/blood.V112.11.1419.1419

Published: 2008

Journal Articles

Anti-D Immunglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura.

Emine Turkkan, MD, Fugen Pekun, MD

Blood (2006) 108 (11): 3967.

https://doi.org/10.1182/blood.V108.11.3967.3967

Published: 2006

Journal Articles

Treatment of Immune-Mediated Thrombocytopenia Purpura with Concurrent IVIg and Platelet Transfusion: A Retrospective Review of 40 Patients.

Joseph E. Spahr, MD, Neeraj Agarwal, M.D., George M. Rodgers, M.D., PhD

Blood (2006) 108 (11): 3972.

https://doi.org/10.1182/blood.V108.11.3972.3972

Published: 2006

NARROW

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Faster Diagnosis of TTP Using New Technoscreen Adamts-13 Activity Assay

Myeloid-Derived Suppressor Cells Increase in Chronic Myeloid Leukemia and Exert Immune Suppressive Activity.

Dose Adjustment and Use of Alternative Eltrombopag Dosing Regimens for the Treatment of Patients with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome

Comparative Net Cost Impact of the Utilization of Romiplostim and Intravenous Immunoglobulin for the Treatment of Patients with Immune Thrombocytopenia in Quebec,

Romiplostim Treatment Mimicking Cyclic Thrombocytopenia In 3 Patients with Chronic Idiopatic Thrombocytopenic Purpura

Characteristics of Sarcoidosis-Associated Immune Thrombocytopenia: a Consecutive Study of 20 Cases.

An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients (Pts) with Myelodysplastic Syndromes (MDS).

A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).

Defining the Molecular Mechanisms Responsible for the ABO High Expresser Phenotype.

PTPN22 Mutation Is Present in An Increased Proportion of ITP Patients.

Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Treatment Pattern and Splenectomy Rate from a Multinational Prospective Observational Study

Immune Thrombocytopenic Purpura Due to Passenger Donor Lymphocytes in Liver Transplantation

Treatment of Idiopathic (autoimmune) Thrombocytopenic Purpura (ITP): A Single Mexican Institution Experience

Deferasirox Efficacy and Safety for the Treatment of Transfusion- Dependent Iron Overload in Patients with a Range of Rare Anemias.

Anti-D Immunglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura.

Treatment of Immune-Mediated Thrombocytopenia Purpura with Concurrent IVIg and Platelet Transfusion: A Retrospective Review of 40 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only